160 related articles for article (PubMed ID: 18494749)
1. Methodological considerations in cost of prostate cancer studies: a systematic review.
Molinier L; Bauvin E; Combescure C; Castelli C; Rebillard X; Soulié M; Daurès JP; Grosclaude P
Value Health; 2008; 11(5):878-85. PubMed ID: 18494749
[TBL] [Abstract][Full Text] [Related]
2. Cost of lung cancer: a methodological review.
Molinier L; Combescure C; Chouaïd C; Daurès JP; Housset B; Fabre D; Grand A; Vergnenègre A
Pharmacoeconomics; 2006; 24(7):651-9. PubMed ID: 16802841
[TBL] [Abstract][Full Text] [Related]
3. Methodological considerations in cost of illness studies on Alzheimer disease.
Costa N; Derumeaux H; Rapp T; Garnault V; Ferlicoq L; Gillette S; Andrieu S; Vellas B; Lamure M; Grand A; Molinier L
Health Econ Rev; 2012 Sep; 2(1):18. PubMed ID: 22963680
[TBL] [Abstract][Full Text] [Related]
4. The cost of cochlear implantation: a review of methodological considerations.
Nadège C; Valérie G; Laura F; Hélène DB; Vanina B; Olivier D; Bernard F; Laurent M
Int J Otolaryngol; 2011; 2011():210838. PubMed ID: 22028715
[TBL] [Abstract][Full Text] [Related]
5. Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review.
Zemedikun DT; Kigozi J; Wynne-Jones G; Guariglia A; Roberts T
PLoS One; 2021; 16(5):e0251406. PubMed ID: 33974661
[TBL] [Abstract][Full Text] [Related]
6. Cost of illness of the prostate cancer in Japan--a time-trend analysis and future projections.
Kitazawa T; Matsumoto K; Fujita S; Seto K; Hanaoka S; Hasegawa T
BMC Health Serv Res; 2015 Oct; 15():453. PubMed ID: 26438194
[TBL] [Abstract][Full Text] [Related]
7. Cost-of-illness studies for bipolar disorder: systematic review of international studies.
Jin H; McCrone P
Pharmacoeconomics; 2015 Apr; 33(4):341-53. PubMed ID: 25576148
[TBL] [Abstract][Full Text] [Related]
8. Cost-of-Illness in Rare Diseases.
Linertová R; García-Pérez L; Gorostiza I
Adv Exp Med Biol; 2017; 1031():283-297. PubMed ID: 29214579
[TBL] [Abstract][Full Text] [Related]
9. Cost comparisons and methodological heterogeneity in cost-of-illness studies: the example of colorectal cancer.
Ó Céilleachair AJ; Hanly P; Skally M; O'Neill C; Fitzpatrick P; Kapur K; Staines A; Sharp L
Med Care; 2013 Apr; 51(4):339-50. PubMed ID: 23358383
[TBL] [Abstract][Full Text] [Related]
10. Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada.
Smith-Palmer J; Takizawa C; Valentine W
BMC Urol; 2019 Mar; 19(1):19. PubMed ID: 30885200
[TBL] [Abstract][Full Text] [Related]
11. [The economic burden of prostate cancer. A systematic literature overview of registry-based studies].
Rencz F; Brodszky V; Varga P; Gajdácsi J; Nyirády P; Gulácsi L
Orv Hetil; 2014 Mar; 155(13):509-20. PubMed ID: 24659744
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Cost of Illness of Three Major Diseases in Japan.
Matsumoto K; Hanaoka S; Wu Y; Hasegawa T
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1934-1940. PubMed ID: 28712721
[TBL] [Abstract][Full Text] [Related]
13. Cost-of-illness studies in nine Central and Eastern European countries.
Brodszky V; Beretzky Z; Baji P; Rencz F; Péntek M; Rotar A; Tachkov K; Mayer S; Simon J; Niewada M; Hren R; Gulácsi L
Eur J Health Econ; 2019 Jun; 20(Suppl 1):155-172. PubMed ID: 31104219
[TBL] [Abstract][Full Text] [Related]
14. Informing health policy in Japan: A mixed-model estimation to compare the cost of illness of cervical cancer and endometrial cancer.
Hayata E; Seto K; Kitazawa T; Matsumoto K; Morita M; Hasegawa T
J Obstet Gynaecol Res; 2016 Apr; 42(4):446-56. PubMed ID: 26712320
[TBL] [Abstract][Full Text] [Related]
15. Cost-of-illness studies in systemic lupus erythematosus: A systematic review.
Zhu TY; Tam LS; Li EK
Arthritis Care Res (Hoboken); 2011 May; 63(5):751-60. PubMed ID: 21557530
[TBL] [Abstract][Full Text] [Related]
16. Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis.
Gordon LG; Tuffaha HW; James R; Keller AT; Lowe A; Scuffham PA; Gardiner RA
Urol Oncol; 2018 Mar; 36(3):91.e7-91.e15. PubMed ID: 29169847
[TBL] [Abstract][Full Text] [Related]
17. The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L
CMAJ; 2000 Apr; 162(7):987-92. PubMed ID: 10763396
[TBL] [Abstract][Full Text] [Related]
18. A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies.
Schnitzler L; Roberts TE; Jackson LJ; Paulus ATG; Evers SMAA
Int J Technol Assess Health Care; 2023 Jun; 39(1):e34. PubMed ID: 37325977
[TBL] [Abstract][Full Text] [Related]
19. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
Fourcade RO; Benedict A; Black LK; Stokes ME; Alcaraz A; Castro R
BJU Int; 2010 Jan; 105(1):49-56. PubMed ID: 20132102
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Cost-of-Illness Studies of Multimorbidity.
Wang L; Si L; Cocker F; Palmer AJ; Sanderson K
Appl Health Econ Health Policy; 2018 Feb; 16(1):15-29. PubMed ID: 28856585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
